Genezen reports that the company became the first CDMO to license CSL’s Cytegrity™ cell line production system that was designed for the production of lentiviral vectors (LVVs). “We have significant, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback